BioSpace News Archive

Drug Development

MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute GvHD

Independent Data Safety Monitoring Board (DSMB) recommends HERACLES trial to continue without modification

April 9, 2019
·
4 min read
Pharm Country

Medunik USA expands access to Siklos® for pediatric sickle cell anemia patients by offering 340B pricing to covered entities through Apexus

Medunik USA, a company dedicated to improving the health and quality of life of Americans with rare diseases, is pleased to announce that Siklos® is now available to safety-net provider locations served by Apexus, the 340B Pricing Program Prime Vendor.

April 9, 2019
·
4 min read
Job Trends

New Report from Vizient Assesses the Challenges for Hospitals in Evaluating and Adopting Innovative Medical Devices

Over the last six years, the U.S. Food and Drug Administration has approved a number of highly innovative medical devices that have revolutionized cardiovascular care.

April 9, 2019
·
3 min read
Deals

Vaxart Announces Pricing of Underwritten Public Offering

Vaxart, Inc. announced the pricing of an underwritten public offering of 9,090,010 shares of common stock, and common warrants to purchase up to an aggregate of 9,090,010 shares of common stock.

April 9, 2019
·
2 min read
Drug Development

New Study Deepens Research Into the Potential Cardiovascular Health Benefits of Supplementation with Nicotinamide Riboside (NR)

Data published in the Journal of American College of Cardiology shows that this novel form of vitamin B3 helps maintain mitochondrial function in an animal model by stimulating a cellular repair pathway; preliminary human data also support future testing of NR in connection with cardiac health

April 9, 2019
·
5 min read
Business

PharmaCielo Appoints New and Extended Medical and Scientific Advisory Board

Advisory Board to guide PharmaCielo’s research and development of special cannabinoids-based formulations and derived products with therapeutic properties

April 9, 2019
·
7 min read
Drug Development

Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes

Pivotal Study to Evaluate Potential of Anti-CD3 Monoclonal Antibody to Intercept Type 1 Diabetes

April 9, 2019
·
5 min read
Policy

Soligenix and the European Medicines Agency Pediatric Committee Reach Agreement on the Pediatric Investigation Plan for SGX942

Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing Authorization Application in Europe

April 9, 2019
·
11 min read
Business

Checkmate Pharmaceuticals Announces Appointment of Keith T. Flaherty, M.D. to its Board of Directors

Checkmate Pharmaceuticals Inc. announced the addition of Keith T. Flaherty, M.D. to its Board of Directors.

April 9, 2019
·
2 min read
Deals

STAAR Surgical to Report First Quarter Results on May 1, 2019

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced that it will release financial results for the first quarter ended March 29, 2019 on Wednesday, May 1, 2019 after the market close.

April 9, 2019
·
2 min read